ReviewAlzheimer's & dementia : the journal of the Alzheimer's Association2025
Improving quality measurement for dementia care.
Review in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Assessment of Dementia Patients Caregivers' Home Safety Knowledge in the Outpatient Setting of Jeddah, Saudi Arabia.Risk management and healthcare policy · 2026Article
- Advancing early and equitable detection of dementia: key learnings/challenges, recent innovations, and future directions.The Gerontologist · 2025Article
- Improving quality measurement for dementia care.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Nearly 7 million Americans are living with Alzheimer's disease or a related dementia (ADRD). Timely detection, quality of care, and access to services for people with ADRD remain poor. Broad acceptance and implementation of quality standards may help improve care processes, outcomes, and inequities in ADRD care. We review existing quality measures for ADRD and identify care domains that lack well-developed measures or for which uptake of existing measures is low. Increasing the use of existing evidence-based ADRD quality measures for health system performance improvement, pragmatic research, and Alternative Payment Models like the Centers for Medicare & Medicaid Services Guiding an Improved Dementia Experience (GUIDE) Model, launched in 2023, may promote changes in care delivery and help address disparities in dementia care. Highlights US dementia care needs better measurement tools to assess quality and inequities. Increased use of current Alzheimer's disease and related dementias quality measures is urgently needed to improve care. Consensus on high-quality dementia care is vital for health system expectations. The Centers for Medicare & Medicaid Services Guiding an Improved Dementia Experience (GUIDE) Model tests a new payment strategy to enhance dementia care quality. Other payers can boost measurement to drive quality care like the GUIDE Model.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.